Wenpeng Xie

Dr. Wenpeng Xie


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
TMTeng Ma
Teng Ma
XWXiangpeng Wang
Xiangpeng Wang
WQWenjing Qu
Wenjing Qu
LYLingsen Yang
Lingsen Yang
JCJing Cheng
Jing Cheng
WXWenpeng Xie
Wenpeng Xie
Knee osteoarthritis (KOA) is an increasingly prevalent heterogeneous disease characterized by cartilage erosion and inflammation. As the main chemical constituent of Angelicae Pubescentis Radix (APR), an anti-inflammatory herbal medicine, the potential biological effects and underlying mechanism of osthole on chondrocytes and KOA progression remain elusive. In this study, the potential effect and mechanism of osthole on KOA were investigated in vitro and in vivo. We found that osthole inhibited IL-1β-induced apoptosis and cartilage matrix degeneration by activating autophagy in rat chondrocytes. In addition, osthole could activate autophagy through phosphorylation of AMPK/ULK1, and AMPK serves as a positive upstream regulator of ULK1. Furthermore, KOA rats treated with osthole showed phosphorylation of the AMPK/ULK1 pathway and autophagy activation, as well as cartilage protection. Collectively, the AMPK/ULK1 signaling pathway can be activated by osthole to enhance autophagy, thereby suppressing KOA development. Osthole may be a novel and effective therapeutic agent for the clinical treatment of KOA.

28 February 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
ZZZhimeng Zhang
Zhimeng Zhang
DYDaotong Yuan
Daotong Yuan
XJXimin Jin
Ximin Jin
WCWenjie Chang
Wenjie Chang
YZYongkui Zhang
Yongkui Zhang
WXWenpeng Xie
Wenpeng Xie
Background: Asperosaponin VI (AVI) is a naturally occurring monosaccharide derived from Dipsacus asperoides renowned for its anti-inflammatory and bone-protective properties.Objective: To elucidate the specific mechanism through which AVI affects chondrocytes in osteoarthritis (OA).Methods: For the in vitro experiments, primary chondrocytes were to elucidate the molecular mechanisms underlying the action of AVI.For the in vivo experiments, rat OA models were established using a modified Hulth method. The severity of knee osteoarthritis was evaluated 8 weeks post-surgery. Micro-CT imaging, hematoxylin-eosin staining, and Safranin O-fast green staining were used to assess degeneration in rat knee joints. Immunohistochemistry techniques were conducted to measure the levels of collagen II, MMP13, Nrf2, GPX4, ACSL4, and HO-1 within cartilage tissues. ELISA assays were performed to measure those of TNF-α, IL -6, and PGE2 in serum samples.Results: AVI alleviated chondrocyte apoptosis and extracellular matrix degradation in rat OA induced by IL-1β. It attenuated the levels of TNF-α, IL-6, and PGE2 while reducing those of Fe2+ and malondialdehyde (MDA). AVI upregulated the expression of Nrf2, HO-1, and GPX4 while downregulating that of ACSL4. Mechanistic studies revealed that ML385-induced inhibition of the Nrf2 signaling pathway reversed the increase in GPX4 and ACSL4 expression and increased Fe2+ and MDA levels; treatment with erastin, a ferroptosis inducer, produced comparable results. In vivo experiments demonstrated that AVI improved the bone volume/tissue volume and trabecular separation values in OA rats; reversed the Osteoarthritis Research Society International score; upregulated Nrf2, HO-1, and GPX4 expression; downregulated ACSL4 and MMP13 expression, and decreased the serum levels of TNF-α, IL-6, and PGE2.Conclusion: Our findings suggest that AVI is a promising therapeutic agent for OA. It exerted its protective effect by regulating the Nrf2/GPX4/HO-1 signaling axis to inhibit cartilage cell ferroptosis and improve osteoarthritis.

27 January 2026 in Digital Health
Verified
Journal Article
Open access
TMTeng Ma
Teng Ma
XLXin Li
Xin Li
ZYZhiping Yu
Zhiping Yu
WQWenjing Qu
Wenjing Qu
WXWenpeng Xie
Wenpeng Xie
HCHaibo Cong
Haibo Cong
Objective: This study aimed to evaluate the quality and reliability of information presented in short videos related to anterior cruciate ligament (ACL) injuries on two major Chinese social media platforms, TikTok and Bilibili. Methods: A systematic search using the keyword “ACL injuries” was conducted to identify the top 100 Chinese videos on TikTok and Bilibili, respectively. The Global Quality Score (GQS) and the modified DISCERN evaluation scale were employed to assess video content reliability and quality. Videos characteristics—including engagement metrics, uploader identity, video length, and content type—were also gathered. Statistical analyses were conducted to examine differences and correlations between platforms, uploader categories, and video quality. Results: Out of 200 videos reviewed, 175 met inclusion criteria. The most common content theme was treatment, found in 59 videos (33.71%). TikTok videos attracted higher user engagement than Bilibili. However, the overall video quality on both platforms was moderate. TikTok videos scored higher on GQS and modified DISCERN than on Bilibili. Engagement on TikTok showed no positive correlation with content quality, while that on Bilibili demonstrated a moderate positive correlation. Videos uploaded by healthcare professionals were more popular but often tended to be shorter in duration. Notably, videos uploaded by individual users often achieved quality scores comparable to, or even exceeding, those of medical professionals and science communicators. Conclusion: TikTok demonstrated higher engagement than Bilibili, but both platforms showed limited quality and reliability in ACL injury-related video content. No strong correlation was observed between video content quality and engagement. These findings highlight the need for improved oversight of ACL injury-related information disseminated through short video platforms in China.

30 June 2026 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
TMTeng Ma
Teng Ma
YLYanchen Liang
Yanchen Liang
JYJie Yang
Jie Yang
XWXiaole Wang
Xiaole Wang
XWXiangpeng Wang
Xiangpeng Wang
WXWenpeng Xie
Wenpeng Xie

4 February 2026 in Journal of Health, Population and Nutrition
Verified
Journal Article
Open access
PDF file
QSQi Sun
Qi Sun
XLXin Li
Xin Li
LDLuming Dou
Luming Dou
NLNianhu Li
Nianhu Li
WXWenpeng Xie
Wenpeng Xie
This study aimed to clarify between serum calcium and mortality in osteoarthritis (OA) patients using NHANES data (2003–2018). A total of 1,249 adult

19 March 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FLFei Liu
Fei Liu
DYDaotong Yuan
Daotong Yuan
ZZZhimeng Zhang
Zhimeng Zhang
RGRui Gong
Rui Gong
XJXimin Jin
Ximin Jin
YZYongkui Zhang
Yongkui Zhang
Osteosarcoma (OS) is the most prevalent primary malignant bone tumor, and chemotherapy resistance represents one of the primary challenges in its treatment. Nobiletin (Nob), a natural compound with anti-tumor properties, has an unclear mechanism of action but may increase the sensitivity of tumor cells to chemotherapy agents. This study explores how Nob enhances the effects of Doxorubicin (Dox) on OS cells. Two OS cell lines (143B and U2OS) were used in vitro experiments, where different concentrations of Nob and Dox were combined to treat the cells. The CCK-8 was used to calculate the cell proliferation inhibition rate, and SynergyFinder 3.0 was employed to assess the synergistic concentration of the interventions. Colony formation and cell scratch assays were used to assess the proliferation and migration potential of the cells. Apoptosis levels were identified by flow cytometry, while the expression of proteins related to apoptosis, endoplasmic reticulum stress (ERS), and the PI3K-AKT pathway was detected by Western blotting and immunofluorescence. Moreover, qPCR was employed to measure the expression levels of associated mRNAs. GO and KEGG analyses were used to confirm the differential biological processes and signaling pathways in OS cells. A tumor xenograft model, complemented with H&E and immunohistochemistry staining, were employed to validate the anti-tumor effects and underlying biological mechanisms of the combined treatment with Nob and Dox. The combined treatment of Nob and Dox markedly inhibited both the proliferation and migration of OS cells, exhibiting a pronounced synergistic effect. The combination treatment led to an increased apoptosis rate, characterized by reduced expression of Bcl-2 and elevated levels of Bax and Caspase3. Additionally, the combination group significantly upregulated ERS-related proteins GRP78, CRT, CHOP and ATF6, while the activity of the PI3K-AKT pathway was notably diminished. In a tumor xenograft model, the combination of Nob and Dox significantly inhibited tumor growth, inducing ERS and apoptosis. This study reveals that Nob enhances Dox-induced ERS and apoptosis by inhibiting the PI3K-AKT pathway, thereby increasing the sensitivity of OS cells to Dox. This discovery offers a promising new strategy for the treatment of OS.